Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
NEW YORK, April 15, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This BCC report, Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets, provides a comprehensive description of conditions and diseases that affect the eye and products used for eye treatment. This report includes information regarding the incidence and prevalence of eye conditions and risk factors associated with those conditions. Major product segments with in-depth market and competitive analysis are included in each segment and discuss ophthalmic devices, diagnostics and surgical procedures. Research and development activities are included with an emphasis on segments that offer benefits to aging populations.
REASONS FOR DOING THE STUDY
The aging of the population around the world will result in a rapid increase in the over age 65 population by 2030, a population that accounts for the highest incidence and prevalence of eye conditions and diseases. This sets the stage for increased research and development activities, speedy market approvals and higher awareness through education. Additionally, current market competitors will endure pressure from the industry to continually provide advances in therapies and equipment and to compete with emerging competitors, who focus significantly on unmet needs of the ophthalmic industry, including treatments for back of the eye conditions. The industry is likely to experience a burst of new products and heavy competition as the ophthalmic market advances.
SCOPE AND FORMAT
This BCC report is designed to be a helpful business tool to provide a thorough evaluation of the ophthalmic device, diagnostic and surgical market. The geographical scope is worldwide, with an emphasis on major markets such as the United States. This report identifies products by product type and, where applicable, by disease type.
Within the global market of ophthalmic devices, diagnostics and surgical equipment, three general areas are identified, with appropriate subsegments discussed. These include:
• Ophthalmic diagnostic market.
- Ophthalmic imaging equipment.
- Nonimaging exam diagnostics.
- Other diagnostic equipment and peripherals.
• Contact lens market.
- Soft lenses.
- Gas permeable lenses.
- Cosmetic lenses.
- Shaping lenses.
• Ophthalmic surgical market.
- Ophthalmic lasers, phacoemulsification systems and related equipment.
- Intraocular lenses.
- Shunts and other drainage devices.
- Other surgical devices and equipment.
Additionally, the market is analyzed in terms of use and focuses on specific diseases and conditions such as cataract treatments, glaucoma treatments and refractive treatments. Each segment provides detailed information of products, current market estimates and market forecasts.
METHODOLOGY
The information for this BCC report was obtained through primary and secondary data collection methods. Primary methods included interviews with key executives, product managers and clinical specialists involved in the ophthalmic drug industry. Secondary methods included published literature in the areas of ophthalmic devices and equipment, investment reports, company literature and various medical and business journals.
All market data pertains to the global market at the manufacturers' level. Data are expressed in current U.S. dollars. The base year of the report is 2012, with historical data provided for 2010 and 2011 and forecast data provided through 2017. Historical, base year and forecast data are provided for each market segment of the report. Competitor market shares are provided for each market segment for the 2012 base year.
ANALYST CREDENTIALS
Melissa Elder is an experienced healthcare market analyst, specializing in prescription and over-the-counter pharmaceuticals, medical devices and emerging healthcare technologies. Ms. Elder has over 20 years of experience in the healthcare industry, specializing in market research for the past 15 years. This experience has given her substantial insight into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.
REPORT HIGHLIGHTS
This report provides:
• An overview of the global markets for ophthalmic devices, diagnostics, and surgery
• Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017
• Identification of products by product type and, where applicable, by disease type
• Examination of general areas identified with appropriate subsegments, including imaging equipment and nonimaging exam diagnostics, the contact lens market, the surgical market, and intraocular lenses, shunts and other drainage devices
• Discussion in terms of use, with a focus on specific diseases and conditions such as cataract treatments, glaucoma treatments, and refractive treatments; each segment provides detailed information of products, current market estimates, and market forecasts
• Comprehensive company profiles of major players in the industry.
TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THE STUDY 2
SCOPE AND FORMAT 2
METHODOLOGY 3
RELATED BCC REPORTS 3
ANALYST CREDENTIALS 3
BCC ON-LINE SERVICES 4
DISCLAIMER 4
CHAPTER 2 SUMMARY 6
OPHTHALMIC MARKET: MAJOR MARKETS SUMMARY 6
SUMMARY TABLE TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET BY SEGMENT, THROUGH 2017 ($ MILLIONS) 7
SUMMARY FIGURE TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET BY SEGMENT, 2010-2017 ($ MILLIONS) 7
LEADING MANUFACTURERS 7
CHAPTER 3 INDUSTRY OVERVIEW 10
OVERVIEW OF VISION 10
STRUCTURE OF THE EYE 10
PATHOLOGY OF VISION 11
TERMINOLOGY 12
TABLE 1 GLOSSARY OF TERMS USED IN OPHTHALMOLOGY 12
EYE TREATMENT SPECIALISTS 18
OPHTHALMOLOGIST 18
OPTOMETRIST 19
OPTICIAN 19
BLINDNESS: A GLOBAL PROBLEM 19
FIGURE 1 HEALTH INSURANCE AND USE OF EYE CARE SERVICES, U.S.
VERSUS CANADA (%) 20
DESCRIPTION OF OPHTHALMIC CONDITIONS AND DISEASES 20
DIABETIC RETINOPATHY 20
AGE-RELATED MACULAR DEGENERATION 21
OCULAR ALLERGIES 22
HERPES SIMPLEX VIRUS KERATITIS 22
CYTOMEGALOVIRUS RETINITIS 22
CATARACTS 23
GLAUCOMA 23
TABLE 2 GLAUCOMA TYPES AND KEY POINTS 23
UVEITIS 24
TABLE 3 KNOWN CAUSES OF UVEITIS 25
TRACHOMA 25
RETINAL DETACHMENT 26
DRY EYE SYNDROME 26
STRABISMUS 27
TABLE 4 STRABISMUS TYPES AND RELATED CATEGORIES 27
OCULAR MUSCLE SPASMS 28
U.S. EYE DISEASE AND CONDITION STATISTICS 29
TABLE 5 ESTIMATED U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE
CONDITIONS AND DISEASES, 2012 DATA 29
GLAUCOMA 30
TABLE 6 PROJECTIONS FOR GLAUCOMA IN THE UNITED STATES BY RACE,
2010-2050 (NO. OF CASES) 30
FIGURE 2 PROJECTIONS FOR GLAUCOMA IN THE UNITED STATES BY RACE,
2010-2050 (NO. OF CASES) 31
CATARACTS 31
TABLE 7 PROJECTIONS FOR CATARACTS IN THE UNITED STATES BY RACE,
2010-2050 (NO. OF CASES) 31
FIGURE 3 PROJECTIONS FOR CATARACTS IN THE UNITED STATES BY RACE,
2010-2050 (NO. OF CASES) 32
AGE-RELATED MACULAR DEGENERATION 32
TABLE 8 PROJECTIONS FOR AGE-RELATED MACULAR DEGENERATION (AMD)
IN THE UNITED STATES BY RACE, 2010-2050 (NO. OF CASES) 32
FIGURE 4 PROJECTIONS FOR AGE-RELATED MACULAR DEGENERATION
(AMD) IN THE UNITED STATES BY RACE, 2010-2050 (NO. OF CASES) 33
DIABETIC RETINOPATHY 33
TABLE 9 PROJECTIONS FOR DIABETIC RETINOPATHY IN THE UNITED
STATES BY RACE, 2010-2050 (NO. OF CASES) 34
FIGURE 5 PROJECTIONS FOR DIABETIC RETINOPATHY IN THE UNITED
STATES BY RACE, 2010-2050 (NO. OF CASES) 34
OCULAR ALLERGIES 34
CYTOMEGALOVIRUS 34
HERPES SIMPLEX VIRUS KERATITIS 35
TRACHOMA 35
UVEITIS 35
NONTRAUMATIC RETINAL DETACHMENT 35
DRY EYE SYNDROME 35
STRABISMUS 36
GLOBAL EYE DISEASE AND CONDITION STATISTICS 36
TABLE 10 ESTIMATED GLOBAL PREVALENCE OF SELECTED EYE
CONDITIONS AND DISEASES, 2010-2012 ($ MILLIONS) 36
GLAUCOMA 37
CATARACTS 37
AGE-RELATED MACULAR DEGENERATION 37
DIABETIC RETINOPATHY 37
OTHER CONDITIONS AFFECTING THE EYE 37
REFRACTIVE ERROR: OVERVIEW AND STATISTICS 38
CHAPTER 4 MARKET TRENDS AND ISSUES 41
GOVERNMENT REGULATION FOR MEDICAL DEVICES 41
U.S. DEVICE REGISTRATION PROCESS 41
EUROPEAN UNION (EU) DEVICE REGISTRATION PROCESS 41
JAPAN'S DEVICE REGISTRATION PROCESS 42
CANADA'S DEVICE REGISTRATION PROCESS 43
GOVERNMENT INTERACTION 43
CONTACT LENS REGULATION AND CONSUMER SAFETY 43
Fairness to Contact Lens Consumers Act 43
TABLE 11 GOVERNMENT BILLS/LAWS RELATED TO CONTACT LENSES AND
MANUFACTURERS 44
AFFORDABLE CARE ACT AND MEDICAL DEVICE TAX 44
THE FDA'S PRECAUTIONS INVOLVING LASIK EYE SURGERY 44
OPHTHALMIC PHARMACEUTICAL/DEVICE RECALLS AND LABEL UPDATES 45
TABLE 12 VISION PRODUCT RECALLS 2004-2012 45
ADVERTISING AND MARKETING 49
TABLE 13 MARKETING AND ADVERTISING EXPENSES FOR SELECTED
OPHTHALMIC MANUFACTURERS/PROVIDERS, 2012 ($ MILLIONS) 51
FDA WARNINGS OF IMPROPER ADVERTISING 51
REFRACTIVE SURGERY PROCEDURE VOLUMES AND PRICES 52
FIGURE 6 ESTIMATED REFRACTIVE SURGERY PROCEDURES IN THE UNITED
STATES BY YEAR, 2005-2012 (NO. OF PROCEDURES) 52
FIGURE 7 ESTIMATED REFRACTIVE SURGERY PRICES IN THE UNITED
STATES BY YEAR, 2005-2012 ($ COST PER EYE) 53
POPULATION DEMOGRAPHICS 53
GLOBAL DEMOGRAPHICS 53
TABLE 14 ESTIMATED GLOBAL POPULATION AND ANNUAL GROWTH BY
SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 (MILLIONS) 54
FIGURE 8 ESTIMATED GLOBAL POPULATION AND ANNUAL GROWTH BY
SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030 (MILLIONS) 54
TABLE 15 GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015
(MILLIONS) 55
FIGURE 9 GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND
PROJECTED 2015 (MILLIONS) 56
Global Life Expectancy 56
TABLE 16 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY,
1980 AND 2010 (YEARS) 56
FIGURE 10 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY,
1980 AND 2010 (YEARS) 57
INDUSTRY ACQUISITIONS, MERGERS AND PARTNERSHIPS 57
ADVANCED MEDICAL OPTICS AND ABBOTT MEDICAL OPTICS 57
ALCON 58
BAUSCH & LOMB 58
CARL ZEISS 59
COOPER COMPANIES, INC. 59
ESCALON MEDICAL CORPORATION 59
HAAG-STREIT AG 60
HALMA PLC 60
KOWA OPTIMED, KOWA COMPANY 60
NIDEK, INC. 60
OPKO HEALTH (OPTOS PLC) 61
REICHERT TECHNOLOGIES 61
TOPCON MEDICAL SYSTEMS 61
ULTRALASE 61
ZIEMER OPHTHALMIC 62
CHAPTER 5 OPHTHALMIC DIAGNOSTICS 64
OVERVIEW 64
TYPES OF DIAGNOSTIC TESTS 64
Visual Acuity Test 64
Dilated Eye Exam 64
Manifest Refraction 65
Pupil Reflex 65
Tonometry Test 65
Ophthalmoscopy 66
Gonioscopy 66
Slit Lamp Examinations 66
Fluorescein Staining 67
Eye Muscle Tests 67
Corneal Thickness 67
Pachymetry 67
Echography 68
PRODUCT DESCRIPTION 68
IMAGING DIAGNOSTICS 68
Optic Nerve Imaging and Related Imaging Technologies 68
Glaucoma-Scope 69
Fundus Cameras 69
Aberrometer 70
Echography and Ophthalmic Ultrasound 70
Corneal Topography 71
Fluorescein Angiography 72
Slit Lamp Photography 72
TABLE 17 SELECT CONDITIONS FOUND THROUGH SLIT LAMP
PHOTOGRAPHY 72
Specular Microscopy 73
NONIMAGING DIAGNOSTICS 73
Tonometer 73
Ophthalmoscope 74
Gonioscope 74
Slit Lamps 75
Pachymeter 75
Perimeter 75
HIGHLIGHTED PRODUCTS 76
3-D OCT System from Topcon 76
Topcon's CA-200 Corneal Analyzer 76
Topcon's SL-3G Slit Lamp 76
VISX WaveScan System 77
Alcon's WaveLight Analyzer 77
Bausch & Lomb Zywave Aberrometer 77
Humphrey Field Analyzer from Carl Zeiss Meditec 77
Carl Zeiss CRS-Master II Topography Wavefront System 77
Carl Zeiss Stratus OCT 78
Carl Zeiss VISUCAM 78
Carl Zeiss Cirrus HD-OCT 78
Canon CF, CR and CX Digital Retinal Cameras 79
Spectralis HRA+OCT by Heidelberg Engineering 80
Tomey TMS-4 Corneal Topographer 80
Tomey TMS-5 Scheimpflug Topographer 80
Tomey RT-7000 Auto Ref-Keratometer/Topographer 81
Tomey OA-1000 Optical Biometer 81
Nidek Orion Auto-Retinal Imaging Device 81
Nidek AFC-210 Fundus Camera 81
Nidek AFC-330 Automated Fundus Camera 81
Nidek OPD-Scan III 81
Optos P200MA 82
Optos OCT/SLO 82
Kowa Nonmydriatic Fundus Cameras with VK-2 Digital Imaging
Software - Kowa Nonmyd 7 83
Kowa's VX-20 Retinal Camera 83
Hoya Surgical Optics iTrace Surgical Workstation 83
MARKET SIZE AND GROWTH 83
TABLE 18 TOTAL GLOBAL MARKET FOR OPHTHALMIC DIAGNOSTIC
EQUIPMENT BY MARKET SEGMENT, THROUGH 2017 ($ MILLIONS) 84
FIGURE 11 TOTAL GLOBAL MARKET FOR OPHTHALMIC DIAGNOSTIC
EQUIPMENT BY MARKET SEGMENT, 2010-2017 ($ MILLIONS) 84
MARKETS BY PRODUCT TYPE 85
Imaging/Digital Equipment 85
TABLE 19 GLOBAL MARKET FOR OPHTHALMIC IMAGING EQUIPMENT BY
PRODUCT TYPE, THROUGH 2017 ($ MILLIONS) 86
FIGURE 12 GLOBAL MARKET FOR OPHTHALMIC IMAGING EQUIPMENT BY
PRODUCT TYPE, 2010-2017 ($ MILLIONS) 86
Nonimaging/Routine Exam Equipment 87
TABLE 20 GLOBAL MARKET FOR OPHTHALMIC NONIMAGING
DIAGNOSTICS/EQUIPMENT BY PRODUCT TYPE, THROUGH 2017 ($ MILLIONS) 88
FIGURE 13 GLOBAL MARKET FOR OPHTHALMIC NONIMAGING
DIAGNOSTICS/EQUIPMENT BY PRODUCT TYPE, 2010-2017 ($ MILLIONS) 88
MARKETS BY WORLD REGION 88
TABLE 21 GLOBAL MARKET FOR OPHTHALMIC DIAGNOSTIC EQUIPMENT BY
GEOGRAPHIC REGION, THROUGH 2017 ($ MILLIONS) 89
FIGURE 14 GLOBAL MARKET FOR OPHTHALMIC DIAGNOSTIC EQUIPMENT
BY GEOGRAPHIC REGION, 2012 AND 2017 ($ MILLIONS) 89
COMPETITIVE STRUCTURE AND MARKET SHARE 90
TABLE 22 COMPETITIVE MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS
BY MANUFACTURERS' REVENUES, 2012 (%/$ MILLIONS) 91
FIGURE 15 COMPETITIVE MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS
BY MANUFACTURERS' REVENUES, 2012 ($ MILLIONS) 92
CHAPTER 6 VISION CORRECTION AND VISION PRESERVATION DEVICES 94
OVERVIEW 94
PRODUCT DESCRIPTION 94
Contact Lens Products 94
Soft (Disposable) Lenses 94
Alcon 94
Bausch & Lomb 95
CooperVision 96
Johnson & Johnson Vision Care and Vistakon 97
Gas Permeable Lenses 97
Bausch & Lomb 97
Cosmetic Lenses 98
Alcon 98
CooperVision 98
Vistakon 98
Shaping Lenses 98
Bausch & Lomb 99
Paragon Vision Sciences 99
Hybrid Lenses 99
RESEARCH AND DEVELOPMENT 99
MARKET SIZE AND GROWTH 100
TABLE 23 TOTAL GLOBAL MARKET FOR CONTACT LENSES BY MARKET
SEGMENT, THROUGH 2017 ($ MILLIONS) 101
FIGURE 16 TOTAL GLOBAL MARKET FOR CONTACT LENSES BY MARKET
SEGMENT, 2010-2017 ($ MILLIONS) 101
SOFT CONTACT LENS MARKET BY PRODUCT TYPE 102
TABLE 24 GLOBAL MARKET FOR SOFT CONTACT LENSES BY PRODUCT TYPE,
THROUGH 2017 ($ MILLIONS) 103
FIGURE 17 GLOBAL MARKET FOR SOFT CONTACT LENSES BY PRODUCT
TYPE, 2010-2017 ($ MILLIONS) 103
MARKETS BY WORLD REGION 103
TABLE 25 GLOBAL MARKET FOR CONTACT LENSES BY GEOGRAPHIC REGION,
THROUGH 2017 ($ MILLIONS) 104
FIGURE 18 GLOBAL MARKET FOR CONTACT LENSES BY GEOGRAPHIC
REGION, 2012 AND 2017 ($ MILLIONS) 104
COMPETITIVE STRUCTURE AND MARKET SHARE 105
TABLE 26 COMPETITIVE MARKET SHARE FOR CONTACT LENSES BY
MANUFACTURERS' REVENUES, 2012 (%/$ MILLIONS) 106
FIGURE 19 COMPRETITIVE MARKET SHARE FO CONTACT LENSES BY
MANUFACTURERS' REVENUES, 2012 ($ MILLIONS) 107
CHAPTER 7 SURGICAL EQUIPMENT 109
OVERVIEW 109
TYPES OF SURGICAL PROCEDURES 109
Corneal Procedures 109
Intracorneal Rings 109
Cornea Transplants (Penetrating Keratoplasty) 109
Deep Anterior Lamellar Corneal Transplant (DLEK) 110
Descemet's Stripping with Endothelial Keratoplasty (DSEK) 110
Radial Keratotomy 110
Limbal Relaxing Incisions (LRI) 111
Lens Procedures 111
Lens Replacements 111
Verisyse Lens Implant 111
Refractive Procedures 111
Mechanical Microkeratome 111
Blade-free Microkeratome 112
LASEK, LASIK AND PRK 112
TABLE 27 LIST OF FDA APPROVED LASERS FOR LASIK, 1998-2011 112
Retinal Procedures 114
Vitreoretinal Surgery 114
Surgical Procedures for Cataracts 114
Phacoemulsification Cataract Surgery 114
Endocapsular Tension Ring 114
TABLE 28 ENDOSCAPULAR TENSION RINGS AVAILABLE BY MANUFACTURER 115
Surgical Procedures for Glaucoma 115
Glaucoma Implant 115
TABLE 29 GLAUCOMA IMPLANTS AVAILABLE BY MANUFACTURER 116
Neodymium:YAG Laser Cyclophotocoagulation (YAG CP) 116
Diode Laser Transscleral Cyclophotocoagulation (Diode CYC) 116
Selective Laser Trabeculoplasty (SLT) 116
Argon Laser Trabeculoplasty (ALT) 116
Laser Peripheral Iridotomy (LPI) 117
Filtering Microsurgery 117
Procedures for Age-Related Macular Degeneration (AMD) 117
Focal Laser Treatment and PDT 117
PRODUCT DESCRIPTION 118
OPHTHALMIC LASERS 118
Blade-free Femtosecond Microkeratome 118
TABLE 30 MICROKERATOME/FEMTOSECOND SYSTEMS BY MANUFACTURER 119
Abbott Medical Optics 119
Alcon Laboratories 120
Bausch & Lomb/Technolas Perfect Vision 120
Carl Zeiss 121
LensAR, Inc. 121
OptiMedica Corp. 121
Technolas Perfect Vision 121
Ziemer Ophthalmic Systems 121
Excimer Laser 122
TABLE 31 EXCIMER LASER SYSTEMS BY MANUFACTURER 122
Abbott Medical Optics 123
Alcon Laboratories 123
Carl Zeiss 123
Nidek Co. 124
Schwind Eye-tech-Solutions 124
Technolas Perfect Vision 124
Nd:YAG Lasers 124
TABLE 32 SELECT YAG LASER SYSTEMS BY MANUFACTURER 125
Other Laser Systems 126
Product Examples 126
PHACOEMULSIFICATION SYSTEMS 127
Alcon 127
Abbott Medical Optics 128
Bausch & Lomb 128
Carl Zeiss 129
LightMed Corporation 129
Optikon 2000 SpA 129
STAAR Surgical 129
INTRAOCULAR LENSES AND OTHER LENS IMPLANTS 129
Alcon, Inc. 130
Abbott Medical Optics 130
Bausch & Lomb 130
Carl Zeiss 131
Hoya Surgical Optics 131
Nidek Co. 132
Ophtec BV 132
STAAR Surgical 132
OTHER EQUIPMENT AND DEVICES 133
Shunts and Drainage Devices 133
Abbott Medical Optics 134
Alcon Laboratories 134
New World Medical 134
SOLX, Inc. 134
STAAR Surgical 134
Telescoping Implantable Device 135
Conductive Keratoplasty (CK) Device 135
Intacs - Intracorneal Rings 135
Artificial Cornea 136
Surgical Microscopes 136
Viscoelastic Materials/Devices 136
Abbott Medical Optics 136
Alcon Laboratories 136
Ophtec BV 137
STAAR Surgical 137
Retinal Surgical Oils 137
Intravitreal Drug Implants 137
Vitreoretinal Instruments 138
KEY PRODUCTS 138
LASERS AND SURGICAL INSTRUMENTS 138
Bausch & Lomb's Hansatome Microkeratome 138
Abbott Medical Optics' IntraLase FS Laser 138
VISX Star S4 Laser System 138
Technolas 217z Laser 138
Bausch & Lomb's Orbscan IIz 139
Alcon's WaveLight Allegretto Wave Excimer 139
Carl Zeiss MEL 80 Laser System 139
Nidek EC-5000CX 139
LENSES 139
Alcon 139
Abbott Medical Optics 140
STAAR Surgical 140
RESEARCH AND DEVELOPMENT 141
MARKET SIZE AND GROWTH 143
TABLE 33 TOTAL GLOBAL MARKET FOR OPHTHALMIC SURGICAL
EQUIPMENT AND DEVICES BY MARKET SEGMENT, THROUGH 2017 ($
MILLIONS)
144
FIGURE 20 TOTAL GLOBAL MARKET FOR OPHTHALMIC SURGICAL
EQUIPMENT AND DEVICES BY MARKET SEGMENT, 2010-2017 ($ MILLIONS) 144
MARKETS BY PRODUCT TYPE 144
Cataract, Vitreoretinal and Other Eye Conditions 144
TABLE 34 GLOBAL MARKET FOR OPHTHALMIC SURGICAL EQUIPMENT AND
DEVICES FOR CATARACT, VITREORETINAL AND OTHER EYE CONDITIONS BY
PRODUCT TYPE, THROUGH 2017 ($ MILLIONS)
145
FIGURE 21 GLOBAL MARKET FOR OPHTHALMIC SURGICAL EQUIPMENT AND
DEVICES FOR CATARACT, VITREORETINAL AND OTHER EYE CONDITIONS BY
PRODUCT TYPE, 2010-2017 ($ MILLIONS)
145
Refractive 146
TABLE 35 GLOBAL MARKET FOR OPHTHALMIC REFRACTIVE SURGERY
EQUIPMENT/PRODUCTS BY PRODUCT TYPE, THROUGH 2017 ($ MILLIONS) 147
FIGURE 22 GLOBAL MARKET FOR OPHTHALMIC REFRACTIVE SURGERY
EQUIPMENT/PRODUCTS BY PRODUCT TYPE, THROUGH 2017 ($ MILLIONS) 147
MARKETS BY WORLD REGION 148
TABLE 36 GLOBAL MARKET FOR OPHTHALMIC SURGERY EQUIPMENT AND
DEVICES BY GEOGRAPHIC REGION, THROUGH 2017 ($ MILLIONS) 149
FIGURE 23 GLOBAL MARKET FOR OPHTHALMIC SURGERY EQUIPMENT AND
DEVICES BY GEOGRAPHIC REGION, 2012 AND 2017 ($ MILLIONS) 149
COMPETITIVE STRUCTURE AND MARKET SHARE 149
TABLE 37 COMPETITIVE MARKET SHARE FOR SURGICAL EQUIPMENT AND
DEVICE BY MANUFACTURERS' REVENUES, 2012 (%/$ MILLIONS) 150
FIGURE 24 COMPETITIVE MARKET SHARE FOR SURGICAL EQUIPMENT AND
DEVICES BY MANUFACTURERS' REVENUES, 2012 ($ MILLIONS) 151
CHAPTER 8 MARKET SUMMARY 153
TOTAL OPHTHALMIC MARKET 153
TABLE 38 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET, THROUGH 2017 ($ MILLIONS) 153
FIGURE 25 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET, 2010-2017 ($ MILLIONS) 153
TOTAL MARKET DISTRIBUTION BY MARKET SEGMENT 154
TABLE 39 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET BY SEGMENT, THROUGH 2017 ($ MILLIONS) 154
FIGURE 26 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET BY SEGMENT, 2010-2017 ($ MILLIONS) 154
TOTAL MARKET DISTRIBUTION BY GEOGRAPHICAL REGION 155
TABLE 40 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET BY GEOGRAPHICAL REGION, THROUGH 2017 ($
MILLIONS)
156
FIGURE 27 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET, BY GEOGRAPHICAL REGION, 2012 AND 2017 ($
MILLIONS)
156
INDUSTRY PARTICIPANTS 157
TABLE 41 INDUSTRY PARTICIPANTS BY PRODUCT TYPE 157
COMPETITIVE ANALYSIS 159
TABLE 42 COMPETITIVE ANALYSIS FOR THE OPHTHALMIC MARKET BY TOP
PROVIDERS AND REVENUES, 2012 ($ MILLIONS) 161
FIGURE 28 COMPETITIVE ANALYSIS FOR THE OPHTHALMIC MARKET, BY
TOP PROVIDERS AND REVENUES, 2012 ($ MILLIONS) 161
CHAPTER 9 TECHNOLOGY 163
CURRENT USES OF TECHNOLOGY 163
ABBOTT MEDICAL OPTIC'S WAVESCAN/CUSTOMVUE TECHNOLOGY 163
CRYSTALENS BY EYEONICS, INC. 163
HYBRID LENSES BY SYNERGEYES, INC. 163
SILICONE HYDROGEL 163
TABLE 43 EXTENDED WEAR GAS PERMEABLE SOFT LENSES BY BRAND 164
SENOFILCON A LENS 164
HIGHLY PERMEABLE LENS TECHNOLOGY 164
IMPLANTABLE CONTACT LENSES 165
RETISERT IMPLANT BY BAUSCH & LOMB 165
ORTHOKERATOLOGY 166
NIKE MAXSIGHT 166
TORSIONAL PHACOEMULSIFICATION 167
ILASIK PROCEDURE 167
PARADIGM MEDICAL/LACE ELETTRONICA 167
HOYA CORPORATION LENS SIMULATION CENTER 168
WELCH ALLYN'S IPHONE OPHTHALMOSCOPE 168
BIOSENSOR TECHNOLOGY AND GLUCOSE MEASUREMENTS 168
PATENT EVALUATION 168
OVERVIEW 168
PATENT INFORMATION FOR OPHTHALMIC DEVICES 169
TABLE 44 U.S. OPHTHALMIC DEVICE PATENTS BY FILING DATE 169
PATENT INFORMATION FOR OPHTHALMIC LASERS 173
TABLE 45 U.S. OPHTHALMIC LASER PATENTS BY FILING DATE 173
EVALUATION OF PATENTS BY DATE 174
Devices 174
TABLE 46 U.S. OPHTHALMIC DEVICE PATENTS BY YEAR ISSUED, 1976-2013 174
FIGURE 29 U.S. OPHTHALMIC DEVICE PATENTS BY YEAR ISSUED 174
Lasers 175
TABLE 47 U.S. OPHTHALMIC LASER PATENTS BY YEAR ISSUED 176
FIGURE 30 U.S. OPHTHALMIC LASER PATENTS BY YEAR ISSUED 176
CHAPTER 10 COMPANY PROFILES 178
IN-DEPTH COMPANY PROFILES 178
ABBOTT MEDICAL OPTICS 178
COMPANY OVERVIEW 178
MARKET PERFORMANCE 179
TABLE 48 ADVANCED MEDICAL OPTICS REVENUE PERFORMANCE,
2010-2012 ($ MILLIONS) 179
ALCON LABORATORIES, INC. 179
COMPANY OVERVIEW 179
MARKET PERFORMANCE 180
TABLE 49 ALCON REVENUE PERFORMANCE, 2011 AND 2012 ($ MILLIONS) 180
BAUSCH & LOMB 181
COMPANY OVERVIEW 181
MARKET PERFORMANCE 181
CARL ZEISS AG 182
COMPANY OVERVIEW 182
MARKET PERFORMANCE 182
COOPERVISION 183
COMPANY OVERVIEW 183
MARKET PERFORMANCE 183
TABLE 50 COOPER COMPANIES REVENUE PERFORMANCE, 2010-2012 ($
MILLIONS) 184
HOYA SURGICAL OPTICS, INC. 184
COMPANY OVERVIEW 184
MARKET PERFORMANCE 184
TABLE 51 HOYA CORPORATION REVENUE PERFORMANCE, 2009-2011 ($
MILLIONS) 185
JOHNSON & JOHNSON VISION CARE 185
COMPANY OVERVIEW 185
MARKET PERFORMANCE 185
TABLE 52 JOHNSON & JOHNSON VISION CARE REVENUE PERFORMANCE,
2010-2012 ($ MILLIONS) 186
LUMENIS LTD. 186
COMPANY OVERVIEW 186
MARKET PERFORMANCE 187
TABLE 53 LUMENIS REVENUE PERFORMANCE, 2009-2011 ($ MILLIONS) 187
NIDEK CO., LTD. 187
COMPANY OVERVIEW 187
MARKET PERFORMANCE 188
TABLE 54 ESTIMATED NIDEK REVENUE PERFORMANCE, 2009-2011 ($
MILLIONS) 188
OPTOS PLC 189
COMPANY OVERVIEW 189
MARKET PERFORMANCE 189
TABLE 55 OPTOS REVENUE PERFORMANCE, 2011 AND 2012 ($ MILLIONS) 189
STAAR SURGICAL COMPANY 190
COMPANY OVERVIEW 190
MARKET PERFORMANCE 190
TABLE 56 STAAR SURGICAL COMPANY REVENUE PERFORMANCE, 2010-2012
($ MILLIONS) 191
TOPCON CORPORATION 191
COMPANY OVERVIEW 191
MARKET PERFORMANCE 192
TABLE 57 TOPCON REVENUE PERFORMANCE, 2010-2012 ($ MILLIONS) 192
MINI PROFILES 192
ACCUTOME, INC. 193
CANON, INC. 193
ESCALON MEDICAL CORPORATION 194
HAAG-STREIT AG 195
HEIDELBERG ENGINEERING GMBH 196
IRIDEX CORPORATION 196
KOWA COMPANY LTD. 197
MARCO OPHTHALMIC, INC. 198
OPHTEC BV 198
TOMEY CORPORATION 199
ZIEMER OPHTHALMIC SYSTEMS AG 199
CHAPTER 11 APPENDICES 202
APPENDIX I: OPHTHALMIC PRODUCT MANUFACTURERS 202
APPENDIX II: ORGANIZATIONS 213
LIST OF TABLES
SUMMARY TABLE TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET BY SEGMENT, THROUGH 2017 ($ MILLIONS) 7
TABLE 1 GLOSSARY OF TERMS USED IN OPHTHALMOLOGY 12
TABLE 2 GLAUCOMA TYPES AND KEY POINTS 23
TABLE 3 KNOWN CAUSES OF UVEITIS 25
TABLE 4 STRABISMUS TYPES AND RELATED CATEGORIES 27
TABLE 5 ESTIMATED U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE
CONDITIONS AND DISEASES, 2012 DATA 29
TABLE 6 PROJECTIONS FOR GLAUCOMA IN THE UNITED STATES BY RACE,
2010-2050 (NO. OF CASES) 30
TABLE 7 PROJECTIONS FOR CATARACTS IN THE UNITED STATES BY RACE,
2010-2050 (NO. OF CASES) 31
TABLE 8 PROJECTIONS FOR AGE-RELATED MACULAR DEGENERATION (AMD)
IN THE UNITED STATES BY RACE, 2010-2050 (NO. OF CASES) 32
TABLE 9 PROJECTIONS FOR DIABETIC RETINOPATHY IN THE UNITED STATES
BY RACE, 2010-2050 (NO. OF CASES) 34
TABLE 10 ESTIMATED GLOBAL PREVALENCE OF SELECTED EYE CONDITIONS
AND DISEASES, 2010-2012 ($ MILLIONS) 36
TABLE 11 GOVERNMENT BILLS/LAWS RELATED TO CONTACT LENSES AND
MANUFACTURERS 44
TABLE 12 VISION PRODUCT RECALLS 2004-2012 45
TABLE 13 MARKETING AND ADVERTISING EXPENSES FOR SELECTED
OPHTHALMIC MANUFACTURERS/PROVIDERS, 2012 ($ MILLIONS) 51
TABLE 14 ESTIMATED GLOBAL POPULATION AND ANNUAL GROWTH BY
SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 (MILLIONS) 54
TABLE 15 GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015
(MILLIONS) 55
TABLE 16 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980
AND 2010 (YEARS) 56
TABLE 17 SELECT CONDITIONS FOUND THROUGH SLIT LAMP PHOTOGRAPHY 72
TABLE 18 TOTAL GLOBAL MARKET FOR OPHTHALMIC DIAGNOSTIC
EQUIPMENT BY MARKET SEGMENT, THROUGH 2017 ($ MILLIONS) 84
TABLE 19 GLOBAL MARKET FOR OPHTHALMIC IMAGING EQUIPMENT BY
PRODUCT TYPE, THROUGH 2017 ($ MILLIONS) 86
TABLE 20 GLOBAL MARKET FOR OPHTHALMIC NONIMAGING
DIAGNOSTICS/EQUIPMENT BY PRODUCT TYPE, THROUGH 2017 ($ MILLIONS) 88
TABLE 21 GLOBAL MARKET FOR OPHTHALMIC DIAGNOSTIC EQUIPMENT BY
GEOGRAPHIC REGION, THROUGH 2017 ($ MILLIONS) 89
TABLE 22 COMPETITIVE MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY
MANUFACTURERS' REVENUES, 2012 (%/$ MILLIONS) 91
TABLE 23 TOTAL GLOBAL MARKET FOR CONTACT LENSES BY MARKET
SEGMENT, THROUGH 2017 ($ MILLIONS) 101
TABLE 24 GLOBAL MARKET FOR SOFT CONTACT LENSES BY PRODUCT TYPE,
THROUGH 2017 ($ MILLIONS) 103
TABLE 25 GLOBAL MARKET FOR CONTACT LENSES BY GEOGRAPHIC REGION,
THROUGH 2017 ($ MILLIONS) 104
TABLE 26 COMPETITIVE MARKET SHARE FOR CONTACT LENSES BY
MANUFACTURERS' REVENUES, 2012 (%/$ MILLIONS) 106
TABLE 27 LIST OF FDA APPROVED LASERS FOR LASIK, 1998-2011 112
TABLE 28 ENDOSCAPULAR TENSION RINGS AVAILABLE BY MANUFACTURER 115
TABLE 29 GLAUCOMA IMPLANTS AVAILABLE BY MANUFACTURER 116
TABLE 30 MICROKERATOME/FEMTOSECOND SYSTEMS BY MANUFACTURER 119
TABLE 31 EXCIMER LASER SYSTEMS BY MANUFACTURER 122
TABLE 32 SELECT YAG LASER SYSTEMS BY MANUFACTURER 125
TABLE 33 TOTAL GLOBAL MARKET FOR OPHTHALMIC SURGICAL EQUIPMENT
AND DEVICES BY MARKET SEGMENT, THROUGH 2017 ($ MILLIONS) 144
TABLE 34 GLOBAL MARKET FOR OPHTHALMIC SURGICAL EQUIPMENT AND
DEVICES FOR CATARACT, VITREORETINAL AND OTHER EYE CONDITIONS BY
PRODUCT TYPE, THROUGH 2017 ($ MILLIONS)
145
TABLE 35 GLOBAL MARKET FOR OPHTHALMIC REFRACTIVE SURGERY
EQUIPMENT/PRODUCTS BY PRODUCT TYPE, THROUGH 2017 ($ MILLIONS) 147
TABLE 36 GLOBAL MARKET FOR OPHTHALMIC SURGERY EQUIPMENT AND
DEVICES BY GEOGRAPHIC REGION, THROUGH 2017 ($ MILLIONS) 149
TABLE 37 COMPETITIVE MARKET SHARE FOR SURGICAL EQUIPMENT AND
DEVICE BY MANUFACTURERS' REVENUES, 2012 (%/$ MILLIONS) 150
TABLE 38 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND SURGICAL
MARKET, THROUGH 2017 ($ MILLIONS) 153
TABLE 39 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND SURGICAL
MARKET BY SEGMENT, THROUGH 2017 ($ MILLIONS) 154
TABLE 40 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND SURGICAL
MARKET BY GEOGRAPHICAL REGION, THROUGH 2017 ($ MILLIONS) 156
TABLE 41 INDUSTRY PARTICIPANTS BY PRODUCT TYPE 157
TABLE 42 COMPETITIVE ANALYSIS FOR THE OPHTHALMIC MARKET BY TOP
PROVIDERS AND REVENUES, 2012 ($ MILLIONS) 161
TABLE 43 EXTENDED WEAR GAS PERMEABLE SOFT LENSES BY BRAND 164
TABLE 44 U.S. OPHTHALMIC DEVICE PATENTS BY FILING DATE 169
TABLE 45 U.S. OPHTHALMIC LASER PATENTS BY FILING DATE 173
TABLE 46 U.S. OPHTHALMIC DEVICE PATENTS BY YEAR ISSUED, 1976-2013 174
TABLE 47 U.S. OPHTHALMIC LASER PATENTS BY YEAR ISSUED 176
TABLE 48 ADVANCED MEDICAL OPTICS REVENUE PERFORMANCE, 2010-2012
($ MILLIONS) 179
TABLE 49 ALCON REVENUE PERFORMANCE, 2011 AND 2012 ($ MILLIONS) 180
TABLE 50 COOPER COMPANIES REVENUE PERFORMANCE, 2010-2012 ($
MILLIONS) 184
TABLE 51 HOYA CORPORATION REVENUE PERFORMANCE, 2009-2011 ($
MILLIONS) 185
TABLE 52 JOHNSON & JOHNSON VISION CARE REVENUE PERFORMANCE,
2010-2012 ($ MILLIONS) 186
TABLE 53 LUMENIS REVENUE PERFORMANCE, 2009-2011 ($ MILLIONS) 187
TABLE 54 ESTIMATED NIDEK REVENUE PERFORMANCE, 2009-2011 ($
MILLIONS) 188
TABLE 55 OPTOS REVENUE PERFORMANCE, 2011 AND 2012 ($ MILLIONS) 189
TABLE 56 STAAR SURGICAL COMPANY REVENUE PERFORMANCE, 2010-2012
($ MILLIONS) 191
TABLE 57 TOPCON REVENUE PERFORMANCE, 2010-2012 ($ MILLIONS) 192
LIST OF FIGURES
SUMMARY FIGURE TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET BY SEGMENT, 2010-2017 ($ MILLIONS) 7
FIGURE 1 HEALTH INSURANCE AND USE OF EYE CARE SERVICES, U.S.
VERSUS CANADA (%) 20
FIGURE 2 PROJECTIONS FOR GLAUCOMA IN THE UNITED STATES BY RACE,
2010-2050 (NO. OF CASES) 31
FIGURE 3 PROJECTIONS FOR CATARACTS IN THE UNITED STATES BY RACE,
2010-2050 (NO. OF CASES) 32
FIGURE 4 PROJECTIONS FOR AGE-RELATED MACULAR DEGENERATION (AMD)
IN THE UNITED STATES BY RACE, 2010-2050 (NO. OF CASES) 33
FIGURE 5 PROJECTIONS FOR DIABETIC RETINOPATHY IN THE UNITED
STATES BY RACE, 2010-2050 (NO. OF CASES) 34
FIGURE 6 ESTIMATED REFRACTIVE SURGERY PROCEDURES IN THE UNITED
STATES BY YEAR, 2005-2012 (NO. OF PROCEDURES) 52
FIGURE 7 ESTIMATED REFRACTIVE SURGERY PRICES IN THE UNITED STATES
BY YEAR, 2005-2012 ($ COST PER EYE) 53
FIGURE 8 ESTIMATED GLOBAL POPULATION AND ANNUAL GROWTH BY
SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030 (MILLIONS) 54
FIGURE 9 GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND
PROJECTED 2015 (MILLIONS) 56
FIGURE 10 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY,
1980 AND 2010 (YEARS) 57
FIGURE 11 TOTAL GLOBAL MARKET FOR OPHTHALMIC DIAGNOSTIC
EQUIPMENT BY MARKET SEGMENT, 2010-2017 ($ MILLIONS) 84
FIGURE 12 GLOBAL MARKET FOR OPHTHALMIC IMAGING EQUIPMENT BY
PRODUCT TYPE, 2010-2017 ($ MILLIONS) 86
FIGURE 13 GLOBAL MARKET FOR OPHTHALMIC NONIMAGING
DIAGNOSTICS/EQUIPMENT BY PRODUCT TYPE, 2010-2017 ($ MILLIONS) 88
FIGURE 14 GLOBAL MARKET FOR OPHTHALMIC DIAGNOSTIC EQUIPMENT BY
GEOGRAPHIC REGION, 2012 AND 2017 ($ MILLIONS) 89
FIGURE 15 COMPETITIVE MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS
BY MANUFACTURERS' REVENUES, 2012 ($ MILLIONS) 92
FIGURE 16 TOTAL GLOBAL MARKET FOR CONTACT LENSES BY MARKET
SEGMENT, 2010-2017 ($ MILLIONS) 101
FIGURE 17 GLOBAL MARKET FOR SOFT CONTACT LENSES BY PRODUCT TYPE,
2010-2017 ($ MILLIONS) 103
FIGURE 18 GLOBAL MARKET FOR CONTACT LENSES BY GEOGRAPHIC REGION,
2012 AND 2017 ($ MILLIONS) 104
FIGURE 19 COMPRETITIVE MARKET SHARE FO CONTACT LENSES BY
MANUFACTURERS' REVENUES, 2012 ($ MILLIONS) 107
FIGURE 20 TOTAL GLOBAL MARKET FOR OPHTHALMIC SURGICAL
EQUIPMENT AND DEVICES BY MARKET SEGMENT, 2010-2017 ($ MILLIONS) 144
FIGURE 21 GLOBAL MARKET FOR OPHTHALMIC SURGICAL EQUIPMENT AND
DEVICES FOR CATARACT, VITREORETINAL AND OTHER EYE CONDITIONS BY
PRODUCT TYPE, 2010-2017 ($ MILLIONS)
145
FIGURE 22 GLOBAL MARKET FOR OPHTHALMIC REFRACTIVE SURGERY
EQUIPMENT/PRODUCTS BY PRODUCT TYPE, THROUGH 2017 ($ MILLIONS) 147
FIGURE 23 GLOBAL MARKET FOR OPHTHALMIC SURGERY EQUIPMENT AND
DEVICES BY GEOGRAPHIC REGION, 2012 AND 2017 ($ MILLIONS) 149
FIGURE 24 COMPETITIVE MARKET SHARE FOR SURGICAL EQUIPMENT AND
DEVICES BY MANUFACTURERS' REVENUES, 2012 ($ MILLIONS) 151
FIGURE 25 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET, 2010-2017 ($ MILLIONS) 153
FIGURE 26 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET BY SEGMENT, 2010-2017 ($ MILLIONS) 154
FIGURE 27 TOTAL GLOBAL OPHTHALMIC DIAGNOSTIC, DEVICE AND
SURGICAL MARKET, BY GEOGRAPHICAL REGION, 2012 AND 2017 ($ MILLIONS) 156
FIGURE 28 COMPETITIVE ANALYSIS FOR THE OPHTHALMIC MARKET, BY TOP
PROVIDERS AND REVENUES, 2012 ($ MILLIONS) 161
FIGURE 29 U.S. OPHTHALMIC DEVICE PATENTS BY YEAR ISSUED 174
FIGURE 30 U.S. OPHTHALMIC LASER PATENTS BY YEAR ISSUED 176
To order this report:
Ophthalmic_Devices Industry: Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article